"The Global Iliac Stent Market was valued at USD 1263 million in 2025 and is projected to reach USD 2412 million by 2034, growing at a CAGR of 7.45%."
The iliac stent market represents a specialized segment within the vascular and endovascular devices industry, primarily focused on treating peripheral arterial disease (PAD) and aortoiliac occlusive conditions. Iliac stents are small mesh-like tubes inserted into the iliac arteries to restore blood flow and prevent arterial collapse or restenosis. These stents play a critical role in minimally invasive interventions for patients with blocked or narrowed arteries in the pelvic region. Increasing global prevalence of lifestyle-related disorders such as obesity, hypertension, and diabetes known risk factors for PAD continues to drive demand for iliac stenting procedures. Advancements in stent materials, drug-eluting technologies, and catheter delivery systems are enhancing clinical outcomes and expanding procedural applications in both elective and emergency settings.
The market is witnessing accelerated growth due to rising geriatric populations, higher procedural adoption in emerging healthcare markets, and improvements in reimbursement policies. Ongoing innovations in self-expanding and balloon-expandable stent designs are improving flexibility, radial strength, and long-term patency rates, offering physicians greater treatment options for complex arterial anatomies. Hospitals and specialty vascular centers are increasingly favoring iliac stents due to shorter hospital stays, reduced recovery time, and improved quality of life for patients. Key players are investing in clinical trials, product launches, and strategic partnerships to gain competitive advantage and strengthen their global footprint. With growing emphasis on endovascular therapies, the iliac stent market is poised for steady evolution and long-term clinical relevance in vascular care.
Report Scope
| Parameter | Detail |
|---|---|
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2026-2034 |
| Market Size-Units | USD billion/Million |
| Market Splits Covered | By Type ,By Artery Lesions ,By End-Users |
| Countries Covered | North America (USA, Canada, Mexico) Europe (Germany, UK, France, Spain, Italy, Rest of Europe) Asia-Pacific (China, India, Japan, Australia, Rest of APAC) The Middle East and Africa (Middle East, Africa) South and Central America (Brazil, Argentina, Rest of SCA) |
| Analysis Covered | Latest Trends, Driving Factors, Challenges, Supply-Chain Analysis, Competitive Landscape, Company Strategies |
| Customization | 10% free customization(up to 10 analyst hours) to modify segments, geographies, and companies analyzed |
| Post-Sale Support | 4 analyst hours, available up to 4 weeks |
| Delivery Format | The Latest Updated PDF and Excel Datafile |
Regional Insights
North America Iliac Stent Market
The North American iliac stent market is characterized by high procedural volumes, well-established healthcare systems, and early adoption of advanced vascular devices. Physicians increasingly prefer iliac stents due to minimally invasive techniques, strong reimbursement frameworks, and clear clinical evidence illustrating quicker recovery and improved patient outcomes. Companies are targeting opportunities in self-expanding and drug-eluting stent technologies tailored for complex arterial anatomies and calcified lesions. Strategic initiatives include streamlining product portfolios to integrate with advanced imaging and navigation tools, as well as expanding into outpatient endovascular care settings aligning with cost efficiencies and evolving care delivery models.
Asia Pacific Iliac Stent Market
Asia Pacific represents the fastest-growing regional segment in the iliac stent market. This growth is fueled by rising prevalence of peripheral arterial disease, improved healthcare infrastructure, and greater procedural access in emerging economies. Opportunities include launching cost-effective stent options and establishing localized manufacturing to meet diverse patient needs. Companies are also leveraging the rapid expansion of endovascular centers and increasing digital engagement with clinicians to accelerate adoption. Forecasts expect robust regional demand driven by rising clinician awareness, supportive regulatory changes, and expanded access to interventional treatments.
Europe Iliac Stent Market
In Europe, the iliac stent market is steadily expanding, supported by investment in advanced medical infrastructure and a preference for evidence-driven, minimally invasive treatments. Growth opportunities lie in highly flexible stent designs suitable for varied European patient anatomies and the introduction of biodegradable or drug-eluting options to address restenosis concerns. Partnerships with specialist vascular centers and multi-center clinical evaluations are vital to building credibility and driving uptake. Furthermore, European demand is being shaped by an increasing inclination toward outpatient procedures and integrated care pathways, encouraging supply chain agility and tailored commercial strategies.
Key Market Insights
- The increasing global incidence of peripheral arterial disease (PAD), particularly among aging populations and individuals with diabetes or hypertension, is driving consistent demand for iliac stent procedures. These stents provide a minimally invasive option for restoring arterial blood flow and preventing limb ischemia.
- Technological advancements in stent design, including drug-eluting and bioresorbable stents, are enhancing treatment efficacy by reducing restenosis rates and improving long-term vessel patency. These innovations are gaining attention from interventional radiologists and vascular surgeons alike.
- Self-expanding and balloon-expandable stents remain the two dominant product categories, with each offering distinct advantages based on lesion complexity and anatomical location. Physicians are increasingly selecting stents based on case-specific performance requirements.
- North America and Europe continue to lead in iliac stent adoption due to well-established healthcare systems, high procedural volumes, and favorable reimbursement structures. However, Asia Pacific is emerging rapidly due to growing cardiovascular disease burden and healthcare infrastructure investments.
- The market is increasingly influenced by the shift toward outpatient endovascular procedures, which offer cost advantages, faster recovery, and lower complication risks compared to traditional surgical interventions.
- Key players are focusing on clinical trials and long-term outcome studies to secure regulatory approvals and clinician trust. Data demonstrating superior safety, deployment precision, and restenosis prevention is critical for competitive positioning.
- Hospital procurement patterns are favoring stent systems that integrate with advanced imaging, navigation, and guidewire technologies. This compatibility enhances procedural success rates and reduces time in the catheterization lab.
- There is growing demand for hybrid stent solutions that combine mechanical support with therapeutic drug delivery. These stents are especially beneficial for patients with diffuse or recurrent arterial blockages in the iliac region.
- Market consolidation through mergers and acquisitions is allowing major medtech firms to expand their endovascular portfolios and access new geographic markets. This consolidation is also enabling economies of scale and portfolio differentiation.
- Increasing awareness among patients and primary care providers regarding early diagnosis and intervention in PAD is promoting the uptake of endovascular treatment options, including iliac stenting, as a frontline therapeutic approach.
Iliac Stent Market Segments Covered In The Report
By Type
- Self-Expandable Stents
- Balloon-Expandable Stents
- Other Types
By Artery Lesions
- Common Iliac Artery Lesions
- Severe Calcified Lesions
- Complete Obstructive Lesions
By End-Users
- Hospitals
- Outpatient Facilities
- Other End-Users
By Geography
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Spain, Italy, Rest of Europe)
- Asia-Pacific (China, India, Japan, Australia, Vietnam, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Key Market Players
Cardinal Health Inc., Abbott Laboratories, Medtronic Plc, Becton, Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc, C. R. Bard Inc., Getinge AB, Cook Medical LLC, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Cordis Corporation, Endologix Inc., LeMaitre Vascular Inc., Alvimedica, Clearstream Technologies Ltd., Jotec GmbH, Translumina GmbH, Vascular Concepts Limited, Lombard Medical Technologies , Acandis GmbH, Gore Medical, Medizintechnik GmbHRecent Industry Developments
- July 2025 – Getinge obtained FDA premarket approval for its iCast covered stent system as a bridging stent, allowing doctors to preserve blood flow between a branch vessel and an endovascular graft in aneurysmal disease cases.
- May 2025 – Boston Scientific commenced the ORION clinical trial to evaluate its EPIC Self‑Expanding Nitinol Stent System in treating iliac artery disease, with patient enrollment beginning in the U.S.
- January 2025 – Bentley InnoMed launched its BeFlow iliac covered stent system in Europe at LINC 2025, presenting a cost-efficient covered option for treating occlusive iliac artery diseases.
What You Receive
• Global Iliac Stent market size and growth projections (CAGR), 2024- 2034• Impact of recent changes in geopolitical, economic, and trade policies on the demand and supply chain of Iliac Stent.
• Iliac Stent market size, share, and outlook across 5 regions and 27 countries, 2025- 2034.
• Iliac Stent market size, CAGR, and Market Share of key products, applications, and end-user verticals, 2025- 2034.
• Short and long-term Iliac Stent market trends, drivers, restraints, and opportunities.
• Porter’s Five Forces analysis, Technological developments in the Iliac Stent market, Iliac Stent supply chain analysis.
• Iliac Stent trade analysis, Iliac Stent market price analysis, Iliac Stent Value Chain Analysis.
• Profiles of 5 leading companies in the industry- overview, key strategies, financials, and products.
• Latest Iliac Stent market news and developments.
The Iliac Stent Market international scenario is well established in the report with separate chapters on North America Iliac Stent Market, Europe Iliac Stent Market, Asia-Pacific Iliac Stent Market, Middle East and Africa Iliac Stent Market, and South and Central America Iliac Stent Markets. These sections further fragment the regional Iliac Stent market by type, application, end-user, and country.
1.1 List of Tables
1.2 List of Figures
2. Iliac Stent Market Latest Trends, Drivers and Challenges, 2024 - 2034
2.1 Iliac Stent Market Overview
2.2 Market Strategies of Leading Iliac Stent Companies
2.3 Iliac Stent Market Insights, 2024 - 2034
2.3.1 Leading Iliac Stent Types, 2024 - 2034
2.3.2 Leading Iliac Stent End-User industries, 2024 - 2034
2.3.3 Fast-Growing countries for Iliac Stent sales, 2024 - 2034
2.4 Iliac Stent Market Drivers and Restraints
2.4.1 Iliac Stent Demand Drivers to 2034
2.4.2 Iliac Stent Challenges to 2034
2.5 Iliac Stent Market- Five Forces Analysis
2.5.1 Iliac Stent Industry Attractiveness Index, 2024
2.5.2 Threat of New Entrants
2.5.3 Bargaining Power of Suppliers
2.5.4 Bargaining Power of Buyers
2.5.5 Intensity of Competitive Rivalry
2.5.6 Threat of Substitutes
3. Global Iliac Stent Market Value, Market Share, and Forecast to 2034
3.1 Global Iliac Stent Market Overview, 2024
3.2 Global Iliac Stent Market Revenue and Forecast, 2024 - 2034 (US$ million)
3.3 Global Iliac Stent Market Size and Share Outlook By Type, 2024 - 2034
3.4 Global Iliac Stent Market Size and Share Outlook By Artery Lesions, 2024 - 2034
3.5 Global Iliac Stent Market Size and Share Outlook By End-Users, 2024 – 2034
3.6 Global Iliac Stent Market Size and Share Outlook By Segment4, 2024 - 2034
3.7 Global Iliac Stent Market Size and Share Outlook by Region, 2024 - 2034
4. Asia Pacific Iliac Stent Market Value, Market Share and Forecast to 2034
4.1 Asia Pacific Iliac Stent Market Overview, 2024
4.2 Asia Pacific Iliac Stent Market Revenue and Forecast, 2024 - 2034 (US$ million)
4.3 Asia Pacific Iliac Stent Market Size and Share Outlook By Type, 2024 - 2034
4.4 Asia Pacific Iliac Stent Market Size and Share Outlook By Artery Lesions, 2024 - 2034
4.5 Asia Pacific Iliac Stent Market Size and Share Outlook By End-Users, 2024 – 2034
4.6 Asia Pacific Iliac Stent Market Size and Share Outlook By Segment4, 2024 - 2034
4.7 Asia Pacific Iliac Stent Market Size and Share Outlook by Country, 2024 - 2034
5. Europe Iliac Stent Market Value, Market Share, and Forecast to 2034
5.1 Europe Iliac Stent Market Overview, 2024
5.2 Europe Iliac Stent Market Revenue and Forecast, 2024 - 2034 (US$ million)
5.3 Europe Iliac Stent Market Size and Share Outlook By Type, 2024 - 2034
5.4 Europe Iliac Stent Market Size and Share Outlook By Artery Lesions, 2024 - 2034
5.5 Europe Iliac Stent Market Size and Share Outlook By End-Users, 2024 – 2034
5.6 Europe Iliac Stent Market Size and Share Outlook By Segment4, 2024 - 2034
5.7 Europe Iliac Stent Market Size and Share Outlook by Country, 2024 - 2034
6. North America Iliac Stent Market Value, Market Share and Forecast to 2034
6.1 North America Iliac Stent Market Overview, 2024
6.2 North America Iliac Stent Market Revenue and Forecast, 2024 - 2034 (US$ million)
6.3 North America Iliac Stent Market Size and Share Outlook By Type, 2024 - 2034
6.4 North America Iliac Stent Market Size and Share Outlook By Artery Lesions, 2024 - 2034
6.5 North America Iliac Stent Market Size and Share Outlook By End-Users, 2024 – 2034
6.6 North America Iliac Stent Market Size and Share Outlook By Segment4, 2024 - 2034
6.7 North America Iliac Stent Market Size and Share Outlook by Country, 2024 - 2034
7. South and Central America Iliac Stent Market Value, Market Share and Forecast to 2034
7.1 South and Central America Iliac Stent Market Overview, 2024
7.2 South and Central America Iliac Stent Market Revenue and Forecast, 2024 - 2034 (US$ million)
7.3 South and Central America Iliac Stent Market Size and Share Outlook By Type, 2024 - 2034
7.4 South and Central America Iliac Stent Market Size and Share Outlook By Artery Lesions, 2024 - 2034
7.5 South and Central America Iliac Stent Market Size and Share Outlook By End-Users, 2024 – 2034
7.6 South and Central America Iliac Stent Market Size and Share Outlook By Segment4, 2024 - 2034
7.7 South and Central America Iliac Stent Market Size and Share Outlook by Country, 2024 - 2034
8. Middle East Africa Iliac Stent Market Value, Market Share and Forecast to 2034
8.1 Middle East Africa Iliac Stent Market Overview, 2024
8.2 Middle East and Africa Iliac Stent Market Revenue and Forecast, 2024 - 2034 (US$ million)
8.3 Middle East Africa Iliac Stent Market Size and Share Outlook By Type, 2024 - 2034
8.4 Middle East Africa Iliac Stent Market Size and Share Outlook By Artery Lesions, 2024 - 2034
8.5 Middle East Africa Iliac Stent Market Size and Share Outlook By End-Users, 2024 – 2034
8.6 Middle East Africa Iliac Stent Market Size and Share Outlook By Segment4, 2024 - 2034
8.7 Middle East Africa Iliac Stent Market Size and Share Outlook by Country, 2024 - 2034
9. Iliac Stent Market Structure
9.1 Key Players
9.2 Iliac Stent Companies - Key Strategies and Financial Analysis
9.2.1 Snapshot
9.2.3 Business Description
9.2.4 Products and Services
9.2.5 Financial Analysis
10. Iliac Stent Industry Recent Developments
11 Appendix
11.1 Publisher Expertise
11.2 Research Methodology
11.3 Annual Subscription Plans
11.4 Contact Information
Get Free Sample
At OG Analysis, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from OG Analysis. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
The Global Iliac Stent Market is estimated to generate USD 1263 million in revenue in 2025.
The Global Iliac Stent Market is expected to grow at a Compound Annual Growth Rate (CAGR) of 7.45% during the forecast period from 2025 to 2034.
The Iliac Stent Market is estimated to reach USD 2412 million by 2034.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
